Chondrosarcoma Orthopaedic Examination Question: Ace Your Test
Key Takeaway
Here are the crucial details you must know about Chondrosarcoma Orthopaedic Examination Question: Ace Your Test. Chondrosarcoma, a malignant cartilage-producing bone tumor, is a common orthopaedic examination question. Diagnosis often involves identifying an expansile lesion with lytic and sclerotic elements, potentially stippled calcification, on CT scans, particularly in older patients (e.g., 60s) and frequently located in the pelvis. Treatment primarily involves wide local excision due to poor chemo- and radio-sensitivity.
A 55-year-old male presents with a 6-month history of dull, aching pain in his left proximal humerus, not relieved by rest. Radiographs reveal a lytic lesion with punctate and ring-and-arc calcifications within the medullary cavity, associated with cortical thickening and periosteal reaction. How do you approach this lesion, and what is your primary differential diagnosis?
Candidate: "Given the patient's age, persistent pain, and the radiographic findings—specifically the chondroid matrix and periosteal reaction—the primary differential is a central chondrosarcoma. My initial steps would be to perform a thorough history and physical, order staging imaging including a CT chest to rule out pulmonary metastasis, and proceed with a CT-guided core needle biopsy to grade the tumor before any definitive surgical intervention."
Jumping directly to treatment (e.g., "I would resect this") without confirming the diagnosis. Candidates often fail to mention staging (staging of the tumor vs staging the patient) or forget to mention the critical need for biopsy to determine the histological grade, which dictates the surgical margin required (intralesional vs wide vs radical).
A systematic response: 1. Differential Diagnosis: Central chondrosarcoma (Grade 1 vs 2) vs. dedifferentiated chondrosarcoma. 2. Staging: Local imaging (MRI) to assess soft tissue and marrow extent + Systemic staging (CT chest) to screen for lung metastasis. 3. Biopsy: Crucial to avoid biopsy tract contamination; must be performed by the treating surgeon or planned to be excised during definitive surgery. 4. Philosophy: Emphasize that surgical planning is 100% dependent on histological grade (Grade 1 vs 2/3).
Following a confirmed diagnosis of a Grade 2 conventional central chondrosarcoma, the patient asks about the role of chemotherapy and radiation therapy for this disease. How do you counsel him?
Candidate: "Conventional chondrosarcomas are notoriously resistant to both conventional chemotherapy and external beam radiation. Therefore, the primary curative modality remains wide surgical resection with clear margins. Adjuvant therapy is typically reserved for cases where wide margins could not be achieved or for specific histological variants like mesenchymal chondrosarcoma."
Suggesting that chemotherapy or radiation are effective "adjuncts" for conventional disease. Failing to qualify that these treatments are generally ineffective for conventional types but might be considered for rare variants (mesenchymal) or specific palliative settings.
The candidate clearly delineates that conventional chondrosarcoma is chemotherapy and radiation-resistant due to poor vascularity and the cartilaginous matrix. They highlight that surgical excision with wide margins is the standard of care. They also demonstrate advanced knowledge by distinguishing this from variants like Mesenchymal Chondrosarcoma, which is the exception to the rule and typically exhibits chemosensitivity.
